CYTOKINETICS INC - COMMON STOCK (CYTK)

CUSIP: 23282W605

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / COMMON STOCK
Shares outstanding
123,724,358
Total 13F shares
131,310,237
Share change
-5,802,849
Total reported value
$6,182,701,180
Put/Call ratio
57%
Price per share
$47.04
Number of holders
342
Value change
-$305,419,938
Number of buys
148
Number of sells
175

Security key

23282W605

Report period

Q4 2024

Institutions

342

Top holders

10

Top shareholders of CYTK - CYTOKINETICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13F
Company
12%
15,252,839
$805,349,898 30 Sep 2024
13F
FMR LLC
13F
Company
9.8%
12,094,254
$638,576,597 30 Sep 2024
13F
VANGUARD GROUP INC
13F
Company
9.5%
11,761,605
$621,012,744 30 Sep 2024
13F
T. Rowe Price Investment Management, Inc.
13F
Company
7.8%
9,689,987
$511,632,000 30 Sep 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
6.3%
7,774,970
$410,518,416 30 Sep 2024
13F
STATE STREET CORP
13F
Company
5.2%
6,458,324
$340,999,507 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
3.9%
4,829,423
$254,993,534 30 Sep 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
2.6%
3,164,945
$167,110,000 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.3%
2,848,584
$150,432,795 30 Sep 2024
13F
RTW INVESTMENTS, LP
13F
Company
2.2%
2,721,158
$143,677,142 30 Sep 2024
13F
Polar Capital Holdings Plc
13F
Company
1.9%
2,337,847
$123,438,322 30 Sep 2024
13F
Boxer Capital, LLC
13F
Company
1.7%
2,100,000
$110,880,000 30 Sep 2024
13F
Pictet Asset Management Holding SA
13F
Company
1.7%
2,088,567
$110,225,636 30 Sep 2024
13F
ARMISTICE CAPITAL, LLC
13F
Company
1.5%
1,896,575
$100,139,160 30 Sep 2024
13F
MARSHALL WACE, LLP
13F
Company
1.5%
1,873,701
$98,931,412 30 Sep 2024
13F
PFM Health Sciences, LP
13F
Company
1.4%
1,757,192
$92,779,738 30 Sep 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
1.3%
1,661,014
$87,701,539 30 Sep 2024
13F
Vestal Point Capital, LP
13F
Company
1.2%
1,500,000
$79,200,000 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
1.1%
1,329,654
$70,205,732 30 Sep 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
1.1%
1,321,391
$69,769,445 30 Sep 2024
13F
JPMORGAN CHASE & CO
13F
Company
1%
1,234,917
$65,203,618 30 Sep 2024
13F
WESTFIELD CAPITAL MANAGEMENT CO LP
13F
Company
0.98%
1,212,886
$64,040,381 30 Sep 2024
13F
Melqart Asset Management (UK) Ltd
13F
Company
0.98%
1,212,258
$64,007,222 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.96%
1,184,789
$62,556,860 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
0.94%
1,168,372
$61,690,112 30 Sep 2024
13F
BROWN ADVISORY INC
13F
Company
0.94%
1,165,991
$61,564,324 30 Sep 2024
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.92%
1,143,830
$60,398,677 30 Sep 2024
13F
Sarissa Capital Management LP
13F
Company
0.9%
1,110,000
$58,608,000 30 Sep 2024
13F
Pentwater Capital Management LP
13F
Company
0.89%
1,100,000
$58,080,000 30 Sep 2024
13F
NORGES BANK
13F
Company
0.8%
992,637
$52,411,234 30 Sep 2024
13F
Hood River Capital Management LLC
13F
Company
0.8%
990,796
$52,314,029 30 Sep 2024
13F
RP Management, LLC
13F
Company
0.79%
980,392
$51,764,698 30 Sep 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.76%
937,191
$49,483,685 30 Sep 2024
13F
ADAR1 Capital Management, LLC
13F
Company
0.74%
911,182
$48,110,410 30 Sep 2024
13F
Bank of New York Mellon Corp
13F
Company
0.73%
907,295
$47,905,166 30 Sep 2024
13F
ORBIMED ADVISORS LLC
13F
Company
0.62%
766,906
$40,492,637 30 Sep 2024
13F
Integral Health Asset Management, LLC
13F
Company
0.61%
750,000
$39,600,000 30 Sep 2024
13F
Deep Track Capital, LP
13F
Company
0.51%
629,906
$33,259,037 30 Sep 2024
13F
TD ASSET MANAGEMENT INC
13F
Company
0.45%
561,018
$29,363,682 30 Sep 2024
13F
Fisher Asset Management, LLC
13F
Company
0.44%
542,284
$28,632,594 30 Sep 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.44%
542,135
$28,624,729 30 Sep 2024
13F
FRANKLIN RESOURCES INC
13F
Company
0.43%
536,447
$29,236,362 30 Sep 2024
13F
Siren, L.L.C.
13F
Individual
0.43%
525,971
$27,771,269 30 Sep 2024
13F
Invesco Ltd.
13F
Company
0.41%
503,091
$26,563,204 30 Sep 2024
13F
Checkpoint Capital L.P.
13F
Company
0.38%
466,813
$24,647,726 30 Sep 2024
13F
Point72 Asset Management, L.P.
13F
Company
0.38%
464,010
$24,499,728 30 Sep 2024
13F
Ensign Peak Advisors, Inc
13F
Company
0.37%
461,836
$24,384,942 30 Sep 2024
13F
Logos Global Management LP
13F
Company
0.32%
400,000
$21,120,000 30 Sep 2024
13F
DAFNA Capital Management LLC
13F
Company
0.32%
398,100
$21,019,680 30 Sep 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.31%
383,176
$20,231,693 30 Sep 2024
13F

Institutional Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q4 2024

As of 31 Dec 2024, CYTOKINETICS INC - COMMON STOCK (CYTK) was held by 342 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 131,310,237 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, FMR LLC, T. Rowe Price Investment Management, Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, RTW INVESTMENTS, LP, PRICE T ROWE ASSOCIATES INC /MD/, and Deep Track Capital, LP. This page lists 345 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
343
Q4 2024 holders
342
Holder diff
-1
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .